retatrutide safety What are the considerations for using retatrutide? ⚠️ BEWARE OF RETATRUTIDE SOLD

The result is intense nausea, bloating , and potentially vomiting

2016;41(10)(Diabetes suppl):3-6

The FDA has not identified colorectal cancer as a confirmed risk for this medication class

ArGLP-1 also reduced total mortality (HR 0.88, 95% CI 0.820.94, p = 0.0001) and hospital admission due to heart failure (HR 0.89, 95% CI 0.820.98, p = 0.013), all without increasing the risk of severe hypoglycemia, pancreatic problems or retinopathy.87 A recent post hoc analysis of CVOT with semaglutide has shown a gain in time free of cardiovascular disease of 1.7 years in those patients with CKD vs

When food intake drops sharply, the body may pull from both fat stores and lean tissue

When microbial balance is compromised, metabolic signaling pathways, including those related to GLP-1, may become less stable over time